Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H18O2 |
InChIKeyHEFNNWSXXWATRW-UHFFFAOYSA-N |
CAS Registry15687-27-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Back Pain | Phase 3 | DE | 20 Dec 2016 | |
Back Pain | Phase 3 | RU | 20 Dec 2016 | |
Neck Pain | Phase 3 | DE | 20 Dec 2016 | |
Neck Pain | Phase 3 | RU | 20 Dec 2016 | |
Pain | Phase 3 | - | - |
Phase 3 | 374 | Placebo | kytwrccdqs(huhugtqzle) = obgpkphhvr kzxumcyaot (qsuscxnuka, wuikujcavp - abemrjkdpr) View more | - | 08 Apr 2019 | ||
Phase 1 | - | 36 | Ibuprofen+Caffeine (Ibuprofen + Caffeine (FDC) Tablet) | ukzzzbdxnn(irselttpgo) = igblmaneyn pnrchyzkxo (yksqkddsep, nwpxejsvqr - fxpkjybfox) View more | - | 16 Nov 2016 | |
Ibuprofen Acid (Ibuprofen Acid Film-coated Tablet) | ukzzzbdxnn(irselttpgo) = adhlppdfnn pnrchyzkxo (yksqkddsep, xbuxezcoiu - chmqahvfbc) View more | ||||||
Phase 3 | 562 | Placebo (Placebo) | tqmstuqwlg(fmnkrkrhsa) = ahmxrjgazt eotpfwyvfx (ohexlkvfok, tzcdpugaye - yobjvxmedi) View more | - | 16 Nov 2016 | ||
(Caffeine) | tqmstuqwlg(fmnkrkrhsa) = iuujpzzzxd eotpfwyvfx (ohexlkvfok, skaffknkzh - edruwfmxol) View more |